Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation
Recruiting
- Conditions
- Atrial Fibrillation
- Interventions
- Other: After radiofrequency ablation of atrial fibrillation
- Registration Number
- NCT05638841
- Lead Sponsor
- Peking University Third Hospital
- Brief Summary
In this study, the continuous inclusion of atrial fibrillation patients treated by catheter ablation in the Department of Cardiology, Peking University Third Hospital, through the collection of clinical data and outpatient follow-up, to explore the risk factors of atrial fibrillation recurrence after catheter ablation and the influencing factors of major clinical events in atrial fibrillation patients, and further guide the management mode of atrial fibrillation patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
-
- Age > 18
-
- ECG or holter electrocardiogram confirmed atrial fibrillation
Read More
Exclusion Criteria
-
- Hematological diseases, autoimmune diseases and malignant tumors
-
- Immobility caused by hemiplegia or severe trauma
-
- The expected survival time is less than 2 years
-
- Poor compliance and high risk of expected loss of follow-up
-
- Disorders of consciousness or Alzheimer's disease
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description atrial fibrillation After radiofrequency ablation of atrial fibrillation After radiofrequency ablation of patients with atrial fibrillation
- Primary Outcome Measures
Name Time Method Compound cardiovascular event 24 months Stroke, hemorrhage, re-hospitalization for atrial fibrillation and heart failure, and all-cause death
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Peking-University-Third-Hospital
🇨🇳Beijing, China